Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands
Abstract Recently, we reported that a native Fasciola hepatica fatty acid binding protein (FABP) termed Fh12 is a powerful anti-inflammatory protein capable of suppressing the LPS-induced expression of inflammatory markers in vivo and in vitro. Because the purification of a protein in native form is...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d0d01490d4d4bc08f507e91640f4f1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1d0d01490d4d4bc08f507e91640f4f1b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1d0d01490d4d4bc08f507e91640f4f1b2021-12-02T12:32:29ZRecombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands10.1038/s41598-017-05735-w2045-2322https://doaj.org/article/1d0d01490d4d4bc08f507e91640f4f1b2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05735-whttps://doaj.org/toc/2045-2322Abstract Recently, we reported that a native Fasciola hepatica fatty acid binding protein (FABP) termed Fh12 is a powerful anti-inflammatory protein capable of suppressing the LPS-induced expression of inflammatory markers in vivo and in vitro. Because the purification of a protein in native form is, in many situations not cost-beneficial and unsuitable for industrial grade scale-up, this study accomplished the task of optimizing the expression and purification of a recombinant form of FABP (Fh15). Additionally, we ascertained whether this molecule could exhibit a similar suppressive effect on TLR-stimulation and inflammatory cytokine expression from macrophages than those previously demonstrated for the native molecule. Results demonstrated that Fh15 suppresses the expression of IL-1β and TNFα in murine macrophages and THP1 Blue CD14 cells. Additionally, Fh15 suppress the LPS-induced TLR4 stimulation. This effect was not impaired by a thermal denaturing process or blocked by the presence of anti-Fh12 antibodies. Fh15 also suppressed the stimulation of various TLRs in response to whole bacteria extracts, suggesting that Fh15 could have a broad spectrum of action. These results support the possibility of using Fh15 as an excellent alternative for an anti-inflammatory drug in preclinical studies in the near future.Marcos J. Ramos-BenítezCaleb Ruiz-JiménezVasti AguayoAna M. EspinoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Marcos J. Ramos-Benítez Caleb Ruiz-Jiménez Vasti Aguayo Ana M. Espino Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands |
description |
Abstract Recently, we reported that a native Fasciola hepatica fatty acid binding protein (FABP) termed Fh12 is a powerful anti-inflammatory protein capable of suppressing the LPS-induced expression of inflammatory markers in vivo and in vitro. Because the purification of a protein in native form is, in many situations not cost-beneficial and unsuitable for industrial grade scale-up, this study accomplished the task of optimizing the expression and purification of a recombinant form of FABP (Fh15). Additionally, we ascertained whether this molecule could exhibit a similar suppressive effect on TLR-stimulation and inflammatory cytokine expression from macrophages than those previously demonstrated for the native molecule. Results demonstrated that Fh15 suppresses the expression of IL-1β and TNFα in murine macrophages and THP1 Blue CD14 cells. Additionally, Fh15 suppress the LPS-induced TLR4 stimulation. This effect was not impaired by a thermal denaturing process or blocked by the presence of anti-Fh12 antibodies. Fh15 also suppressed the stimulation of various TLRs in response to whole bacteria extracts, suggesting that Fh15 could have a broad spectrum of action. These results support the possibility of using Fh15 as an excellent alternative for an anti-inflammatory drug in preclinical studies in the near future. |
format |
article |
author |
Marcos J. Ramos-Benítez Caleb Ruiz-Jiménez Vasti Aguayo Ana M. Espino |
author_facet |
Marcos J. Ramos-Benítez Caleb Ruiz-Jiménez Vasti Aguayo Ana M. Espino |
author_sort |
Marcos J. Ramos-Benítez |
title |
Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands |
title_short |
Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands |
title_full |
Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands |
title_fullStr |
Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands |
title_full_unstemmed |
Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands |
title_sort |
recombinant fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/1d0d01490d4d4bc08f507e91640f4f1b |
work_keys_str_mv |
AT marcosjramosbenitez recombinantfasciolahepaticafattyacidbindingproteinsuppressestolllikereceptorstimulationinresponsetomultiplebacterialligands AT calebruizjimenez recombinantfasciolahepaticafattyacidbindingproteinsuppressestolllikereceptorstimulationinresponsetomultiplebacterialligands AT vastiaguayo recombinantfasciolahepaticafattyacidbindingproteinsuppressestolllikereceptorstimulationinresponsetomultiplebacterialligands AT anamespino recombinantfasciolahepaticafattyacidbindingproteinsuppressestolllikereceptorstimulationinresponsetomultiplebacterialligands |
_version_ |
1718394024256077824 |